{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/en\/","title":"Mortality in Patients with HIV: The Shift to Age-Related Diseases - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"mpUVkaxEoX\"><a href=\"https:\/\/themedicalxchange.com\/en\/2011\/02\/27\/18th-conference-on-retroviruses-and-opportunistic\/\">Mortality in Patients with HIV: The Shift to Age-Related Diseases<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/en\/2011\/02\/27\/18th-conference-on-retroviruses-and-opportunistic\/embed\/#?secret=mpUVkaxEoX\" width=\"600\" height=\"338\" title=\"&#8220;Mortality in Patients with HIV: The Shift to Age-Related Diseases&#8221; &#8212; The Medical Xchange\" data-secret=\"mpUVkaxEoX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2011\/02\/CROI_slides_Figure_1.jpg","thumbnail_width":2200,"thumbnail_height":1650,"description":"Boston \u2013 Between 2005 and 2009, when the most recent analysis was conducted, only 15% of deaths in a human immunodeficiency virus (HIV) cohort could be directly attributed to immune dysfunction. The remaining 85% of deaths were due to other causes including heart disease, liver disease, and non-acquired immunodeficiency syndrome (AIDS) malignancies. These figures emphasize the importance of a major reorientation in HIV care in which new emphasis has been placed on identifying which antiretroviral agents pose the least risk for exacerbating disease processes in major end organs. Based on data presented at the 18thCROI, this information continues to evolve in important ways. New data has been presented on antiretrovirals in relation to kidney function, cardiovascular risk, and dementia. Separating the effects of HIV from the effects of the therapies is often challenging, but it is now clear that antiretroviral agents differ for the specific risks they pose in regard to age-related diseases. This encourages treatment strategies that consider long-term health on top of HIV suppression."}